Edgewise Therapeutics, Inc. EWTX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $157.28M+3.9% | $151.39M+5.0% | $144.17M+3.8% | $138.91M+2.1% | $136.03M+7.1% | ||
| $42.28M+5.7% | $40.02M+8.7% | $36.8M+3.3% | $35.63M+4.8% | $34.01M+6.7% | ||
| $199.56M+4.3% | $191.41M+5.8% | $180.97M+3.7% | $174.54M+2.6% | $170.04M+7.1% | ||
| -$199.56M-4.3% | -$191.41M-5.8% | -$180.97M-3.7% | -$174.54M-2.6% | -$170.04M-7.1% | ||
| -$176.01M-4.9% | -$167.8M-6.7% | -$157.24M-4.3% | -$150.7M-3.2% | -$146.09M-9.2% | ||
| -$1.67-1.8% | -$1.64-3.8% | -$1.58-1.9% | -$1.550.0% | -$1.55-6.9% | ||
| -$197.5M-4.3% | -$189.37M-5.9% | -$178.88M-3.7% | -$172.45M-2.7% | -$167.95M-7.1% | ||
| -$199.56M-4.3% | -$191.41M-5.8% | -$180.97M-3.7% | -$174.54M-2.6% | -$170.04M-7.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Edgewise Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Edgewise Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.